Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 12 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
Φίλτρα: Συντάκτης is Roilides, Emmanuel  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Roilides, E., Simitsopoulou M., Katragkou A., & Walsh T. J. (2009).  Host immune response against Scedosporium species.. Med Mycol. 47(4), 433-40.
Roilides, E., Carlesse F., Tawadrous M., Leister-Tebbe H., Conte U., Raber S., et al. (2020).  Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia.. Pediatr Infect Dis J. 39(4), 305-309.
Roilides, E., Kontoyiannis D. P., & Walsh T. J. (2012).  Host defenses against zygomycetes.. Clin Infect Dis. 54 Suppl 1, S61-6.
Roilides, E., & Simitsopoulou M. (2017).  Immune responses to Mucorales growth forms: Do we know everything?. Virulence. 8(8), 1489-1491.
Roilides, E. (2011).  Invasive candidiasis in neonates and children.. Early Hum Dev. 87 Suppl 1, S75-6.
Roilides, E., & Antachopoulos C. (2016).  Isavuconazole: an azole active against mucormycosis.. Lancet Infect Dis. 16(7), 761-762.
Roilides, E., & Simitsopoulou M. (2010).  Local innate host response and filamentous fungi in patients with cystic fibrosis.. Med Mycol. 48 Suppl 1, S22-31.
Roilides, E., Lyman C. A., Panagopoulou P., & Chanock S. (2003).  Immunomodulation of invasive fungal infections.. Infect Dis Clin North Am. 17(1), 193-219.
Roilides, E., Antachopoulos C., & Simitsopoulou M. (2014).  Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs.. Mycoses. 57 Suppl 3, 40-7.
Roilides, E., Zaoutis T. E., Katragkou A., Benjamin D. K., & Walsh T. J. (2009).  Zygomycosis in neonates: an uncommon but life-threatening infection.. Am J Perinatol. 26(8), 565-73.
Roilides, E., Carlesse F., Leister-Tebbe H., Conte U., Yan J. L., Liu P., et al. (2019).  A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age.. Pediatr Infect Dis J. 38(3), 275-279.
Roilides, E., & Antachopoulos C. (2012).  30th ESPID annual meeting in Thessaloniki, Greece: three decades of ESPID.. Pediatr Infect Dis J. 31(10), 1078-9.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.